Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.

Abstract:

BACKGROUND:It is unclear whether new treatment modalities have improved the survival of follicular lymphoma patients. Some data show that there has been no improvement in survival in the last 3 decades of the 20th century, whereas the results of recent retrospective studies suggest that evolving therapy has improved the outcome for follicular lymphoma patients. METHODS:To evaluate the impact of evolving therapies for follicular lymphoma, particularly the introduction of rituximab, the overall survival (OS), failure-free survival (FFS), and survival after recurrence (SAR) was analyzed in 438 advanced-stage follicular lymphoma patients enrolled in consecutive Gruppo Italiano Studio Linfomi (GISL) trials between 1988 and 2004. RESULTS:A stepwise improvement in FFS and a significant reduction in the hazard ratio was observed with succeeding studies. Cox regression analysis showed an improvement over time for OS, with a decline in the hazard ratio particularly evident in the group treated with rituximab. Furthermore, the SAR significantly improved in the group of patients treated with chemotherapy + rituximab. CONCLUSIONS:After adjusting for all parameters with an impact on FFS and OS, the results of multivariate analysis suggest that rituximab therapy has a favorable effect on the prognosis of follicular lymphoma. The data show that FFS and OS have significantly improved in advanced-stage follicular lymphoma patients treated on GISL protocols during the last 18 years. These improvements are related to evolving front-line and salvage therapies, particularly the introduction of rituximab in combination with chemotherapy.

journal_name

Cancer

journal_title

Cancer

authors

Sacchi S,Pozzi S,Marcheselli L,Bari A,Luminari S,Angrilli F,Merli F,Vallisa D,Baldini L,Brugiatelli M,Italian Lymphoma Study Group.

doi

10.1002/cncr.22649

subject

Has Abstract

pub_date

2007-05-15 00:00:00

pages

2077-82

issue

10

eissn

0008-543X

issn

1097-0142

journal_volume

109

pub_type

杂志文章,多中心研究

相关文献

CANCER文献大全
  • Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma.

    abstract:BACKGROUND:Karyotypic abnormalities in sporadic Burkitt lymphoma (BL) have been described extensively. However, to the authors' knowledge, very limited studies have focused on the secondary chromosomal abnormalities in pediatric BL as compared with those of adult BL and on their prognostic impact. METHODS:A retrospect...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22089

    authors: Onciu M,Schlette E,Zhou Y,Raimondi SC,Giles FJ,Kantarjian HM,Medeiros LJ,Ribeiro RC,Pui CH,Sandlund JT

    更新日期:2006-09-01 00:00:00

  • Atypical human T-cell lymphotropic virus type-I-associated T-cell lymphoma in a low-prevalence Alaska Native population. Implications for disease surveillance.

    abstract::An atypical case of adult T-cell leukemia/lymphoma (ATL) associated with human T-cell lymphotropic virus type I (HTLV-I) occurred in a 46-year-old Inupiat Eskimo man with no behavioral risk factors for HTLV-I infection. The case was characterized by lack of atypical circulating lymphocytes, hypercalcemia, and opportun...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930615)71:12<4072::aid-cncr282

    authors: Davidson M,Braziel RM,Lairmore MD,Jacobson S,Sprott JM,Tucker SB,Levine PH,Kaplan JE

    更新日期:1993-06-15 00:00:00

  • Small bore catheter drainage and sclerotherapy for malignant pleural effusions.

    abstract::The accumulation of large amounts of fluid in the pleural space is a common sequela of disseminated carcinomatosis. Traditional management has included therapeutic thoracentesis or the placement of a large bore chest tube for drainage with the subsequent installation of a sclerosing agent in an attempt to achieve pleu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890915)64:6<1218::aid-cncr2820

    authors: Parker LA,Charnock GC,Delany DJ

    更新日期:1989-09-15 00:00:00

  • Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.

    abstract:BACKGROUND:Postchemotherapy surgery is an essential component in the management of patients with metastatic germ cell tumors (GCT). The authors assessed their institutional experience of retroperitoneal lymph node dissection (RPLND) after multiple chemotherapy regimens for advanced GCT. METHODS:By analyzing the instit...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22440

    authors: Eggener SE,Carver BS,Loeb S,Kondagunta GV,Bosl GJ,Sheinfeld J

    更新日期:2007-02-01 00:00:00

  • A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer.

    abstract:BACKGROUND:For patients with stage III through IVB head and neck squamous cell carcinoma (HNSCC), concurrent high-dose cisplatin plus radiation therapy is a widely accepted standard of care. HNSCC tumors that express high levels of vascular endothelial growth factor have been associated with a worse prognosis, and beva...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27498

    authors: Fury MG,Lee NY,Sherman E,Lisa D,Kelly K,Lipson B,Carlson D,Stambuk H,Haque S,Shen R,Kraus D,Shah J,Pfister DG

    更新日期:2012-10-15 00:00:00

  • Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma.

    abstract:BACKGROUND:Fadrozole hydrochloride (CGS 16949A) is a highly potent, nonsteroidal aromatase inhibitor that significantly lowers estrogen levels in postmenopausal women and can be effective therapy for patients with advanced hormone-dependent breast carcinoma. Circulating estradiol, estrone, and estrone sulfate are reduc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990101)85:1<100::aid-cnc

    authors: Costa LA,Kopreski MS,Demers LM,Chinchilli VM,Santen RJ,Harvey HA,Lipton A

    更新日期:1999-01-01 00:00:00

  • Establishment and characterization of a human T-cell lymphoblastic lymphoma cell line (HT-1) carrying an inversion of chromosome 14.

    abstract::A new human lymphoblastic lymphoma cell line was established (designated HT-1) from the pleural fluid lymphoma cells of a patient with lymphoblastic lymphoma of T-cell type. The HT-1 cells expressed CD1, CD2, CD3, CD4, CD5, CD7, CD8, CD57, and terminal deoxynucleotidyl transferase (TdT) but lacked B-cell-associated an...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.2820690527

    authors: Abe M,Tasaki K,Nozawa Y,Tominaga K,Fukuhara S,Ohsato T,Wakasa H

    更新日期:1992-03-01 00:00:00

  • Estrogen and progesterone receptors in ovarian cancer.

    abstract::To determine whether steroid hormone receptor expression is clinically relevant in ovarian cancer, cytoplasmic and nuclear estrogen (ER) and progesterone (PR) receptor levels have been measured and their concentration calculated by Scatchard analysis. Of 89 samples from patients with non-pretreated epithelial ovarian ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900201)65:3<486::aid-cncr28206

    authors: Harding M,Cowan S,Hole D,Cassidy L,Kitchener H,Davis J,Leake R

    更新日期:1990-02-01 00:00:00

  • Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas.

    abstract:BACKGROUND:Soft tissue sarcomas of the head and neck represent uncommon malignant neoplasms. With the exception of orbital and parameningeal sites, the treatment of sarcomas in the head and neck has not been standardized. The authors used a prospectively collected database of adult soft tissue sarcomas to identify prog...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940715)74:2<697::aid-cncr28207

    authors: Kraus DH,Dubner S,Harrison LB,Strong EW,Hajdu SI,Kher U,Begg C,Brennan MF

    更新日期:1994-07-15 00:00:00

  • Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study.

    abstract:BACKGROUND:The combination of paclitaxel with cisplatin or carboplatin has become the preferred chemotherapy regimen in the treatment of epithelial ovarian carcinoma. Anthracyclines also have activity in this disease. We conducted a Phase II study by using the combination of paclitaxel, cisplatin, and epirubicin for th...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20001001)89:7<1547::aid-cncr19>3

    authors: Papadimitriou CA,Moulopoulos LA,Vlahos G,Voulgaris Z,Kiosses E,Georgoulias N,Gika D,Diakomanolis E,Michalas S,Dimopoulos MA

    更新日期:2000-10-01 00:00:00

  • The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.

    abstract:BACKGROUND:Patients with myeloproliferative neoplasms (MPNs) including polycythemia vera, essential thrombocythemia, and myelofibrosis, are faced with oppressive symptom profiles that compromise daily functioning and quality of life. Among these symptoms, sexuality-related symptoms have emerged as particularly prominen...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30013

    authors: Geyer HL,Andreasson B,Kosiorek HE,Dueck AC,Scherber RM,Martin KA,Butler KA,Harrison CN,Radia DH,Cervantes F,Kiladjian JJ,Reiter A,Birgegard G,Passamonti F,Senyak Z,Vannucchi AM,Paoli C,Xiao Z,Samuelsson J,Mesa RA

    更新日期:2016-06-15 00:00:00

  • Non-Hodgkin's lymphoma in children.

    abstract::Until recently the prognosis of childhood non-Hodgkin's lymphoma has been poor. A program of combination chemotherapy and involved area radiotherapy was instituted in the Department of Pediatrics at Roswell Park Memorial Institute in 1971. Thirty-one biopsy proven untreated children entered this study. There were 4 St...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197805)41:5<1997::aid-cncr282041

    authors: Brecher ML,Sinks LF,Thomas RR,Freeman AI

    更新日期:1978-05-01 00:00:00

  • Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer.

    abstract::Plasma TSH and thyroxine levels were measured in 74 early breast cancer patients and 53 with advanced disease, 77 patients with cancer arising in other organs and 67 healthy women of similar age. The mean plasma TSH levels were higher in the breast cancer cases than the other two groups; the difference was statistical...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197802)41:2<666::aid-cncr2820410

    authors: Rose DP,Davis TE

    更新日期:1978-02-01 00:00:00

  • Ganglioside composition of human neuroblastomas. Correlation with prognosis. A Pediatric Oncology Group Study.

    abstract::The ganglioside composition of neuroblastoma samples from 53 patients was determined. Tumor sites included the adrenals (15), and the thoracic (20), abdominal (15), and pelvic (3) areas. Age of the patients at the time of surgery ranged from 1 day to over 10 years and the Stage of the tumors from A to D. Differences i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19851201)56:11<2640::aid-cncr282

    authors: Schengrund CL,Repman MA,Shochat SJ

    更新日期:1985-12-01 00:00:00

  • Malignant lymphoma with primary manifestation in the gonad: a clinicopathologic study of 38 patients.

    abstract::This study is based on 38 patients, each of whom had a malignant lymphoma in which the gonad was the site of the main tumor mass at the time of diagnosis. Histiocytic lymphoma was the predominant type in the 27 male patients; in the 11 female patients, poorly differentiated lymphocytic lymphoma was the most frequent t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800201)45:3<561::aid-cncr28204

    authors: Paladugu RR,Bearman RM,Rappaport H

    更新日期:1980-02-01 00:00:00

  • Chemotherapy in patients with recurrent and progressive central neurocytoma.

    abstract:BACKGROUND:Recurrent central neurocytoma is very rare and to the authors' knowledge data regarding its response to chemotherapy currently are not available. METHODS:Three patients with progressive neurocytoma received chemotherapy after their informed consent was obtained. Disease recurred in two patients after surger...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(20000101)88:1<169::aid-cnc

    authors: Brandes AA,Amistà P,Gardiman M,Volpin L,Danieli D,Guglielmi B,Carollo C,Pinna G,Turazzi S,Monfardini S

    更新日期:2000-01-01 00:00:00

  • A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.

    abstract:BACKGROUND:The necessity to develop more effective chemotherapy regimens in advanced nonsmall cell lung carcinoma (NSCLC) prompted the authors to evaluate the paclitaxel-ifosfamide-cisplatin (PIC) combination, developed on the basis of high individual single-agent activity, in vitro synergism, and tolerance as determin...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20000815)89:4<774::aid-cncr9>3.0

    authors: Kosmas C,Tsavaris NB,Polyzos A,Kalofonos HP,Sepsas E,Malamos NA,Vadiaka M,Dosios T,Antonopoulos MJ

    更新日期:2000-08-15 00:00:00

  • Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis.

    abstract::Disparities in minorities' representation in cancer clinical trials have been shown only in adult populations, which suggest that the main causes of these disparities relate to health system-based barriers, including issues of poverty (lack of insurance), poor access to trials, and an inadequate number of clinical tri...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23201

    authors: Colon-Otero G,Smallridge RC,Solberg LA Jr,Keith TD,Woodward TA,Willis FB,Dunn AN

    更新日期:2008-02-01 00:00:00

  • Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.

    abstract:BACKGROUND:Although various mechanisms have been recognized as being associated with the development of resistance to imatinib mesylate in vitro and in clinical situations, their relative significance and contributions remain poorly understood, as is the sequence of events leading to the selection of the resistant phen...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20131

    authors: Scappini B,Gatto S,Onida F,Ricci C,Divoky V,Wierda WG,Andreeff M,Dong L,Hayes K,Verstovsek S,Kantarjian HM,Beran M

    更新日期:2004-04-01 00:00:00

  • Primary tumors of the trachea. Results of radiation therapy.

    abstract::From 1959 to 1986, 24 patients with primary malignant tumors of the trachea received radiotherapy as all or part of treatment. Common presentations included respiratory symptoms in 20 patients and hemoptysis in 15. Thirteen patients had squamous carcinomas with undifferentiated and adenoid cystic cancers in five and f...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890615)63:12<2429::aid-cncr282

    authors: Fields JN,Rigaud G,Emami BN

    更新日期:1989-06-15 00:00:00

  • Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.

    abstract:BACKGROUND:Achieving a pathologic complete response (pCR) with neoadjuvant chemotherapy (NAC) in patients with muscle-invasive bladder cancer (MIBC) has been associated with improved overall survival (OS). This study was aimed at evaluating the impact of pathologic downstaging (pDS; ie, a pT stage at least 1 stage lowe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32169

    authors: Martini A,Jia R,Ferket BS,Waingankar N,Plimack ER,Crabb SJ,Harshman LC,Yu EY,Powles T,Rosenberg JE,Pal SK,Vaishampayan UN,Necchi A,Wiklund NP,Mehrazin R,Mazumdar M,Sfakianos JP,Galsky MD

    更新日期:2019-09-15 00:00:00

  • The significance of microsatellite instability in predicting the development of metachronous multiple colorectal carcinomas in patients with nonfamilial colorectal carcinoma.

    abstract:BACKGROUND:Patients with metachronous multiple colorectal carcinomas have been reported to have a higher frequency of a family history of colorectal carcinoma, associated colorectal adenomas, and extracolonic malignancies. These clinicopathologic factors also are considered to be related to the development of metachron...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Masubuchi S,Konishi F,Togashi K,Okamoto T,Senba S,Shitoh K,Kashiwagi H,Kanazawa K,Tsukamoto T

    更新日期:1999-05-01 00:00:00

  • Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.

    abstract:BACKGROUND:Supratentorial gangliogliomas (GGs) are rare tumors of the central nervous system and are commonly associated with chronic seizures. To date, only case reports and small series of patients with short-term follow-up have been available for the assessment of the potential of GGs to recur and progress. METHODS...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20332

    authors: Luyken C,Blümcke I,Fimmers R,Urbach H,Wiestler OD,Schramm J

    更新日期:2004-07-01 00:00:00

  • Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.

    abstract:BACKGROUND:Colorectal cancer (CRC) develops through the alteration of several critical pathways. This study was aimed at evaluating the influence of critical pathways on survival outcomes for patients with CRC. METHODS:Targeted next-generation sequencing of 40 genes included in the 5 critical pathways of CRC (WNT, P53...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30760

    authors: Lee DW,Han SW,Cha Y,Bae JM,Kim HP,Lyu J,Han H,Kim H,Jang H,Bang D,Huh I,Park T,Won JK,Jeong SY,Park KJ,Kang GH,Kim TY

    更新日期:2017-09-15 00:00:00

  • Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.

    abstract:BACKGROUND:Low-grade gliomas (LGGs) and low-grade glioneuronal tumors (LGGNTs) diagnosed during the first year of life carry unique clinical characteristics and challenges in management. However, data on the treatment burden, outcomes, and morbidities are lacking. METHODS:A retrospective study of LGGs and LGGNTs diagn...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31918

    authors: Liu APY,Hastings C,Wu S,Bass JK,Heitzer AM,Ashford J,Vestal R,Hoehn ME,Ghazwani Y,Acharya S,Conklin HM,Boop F,Merchant TE,Gajjar A,Qaddoumi I

    更新日期:2019-04-01 00:00:00

  • Some considerations in the design of new antineoplastic agents.

    abstract::The design of many antineoplastic agents has been based on atom or group replacement in normal metabolites. New dimensions are being added to this approach by the synthesis of transition state, bisubstrate and "suicide" inhibitors. These provide greater potency and in some cases selectivity. Leads for differential sen...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197707)40:1+<529::aid-cncr282040

    authors: Handschumacher RE

    更新日期:1977-07-01 00:00:00

  • Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis.

    abstract:BACKGROUND:Curative resection does not guarantee long term survival for the patient with extrahepatic bile duct carcinoma because of the possibility of metastases to the liver (LM). Expression of mucin core protein-1 (MUC1), sialyl-Le(x), and sialosyl-Tn in bile duct carcinoma was determined and compared with LM and pr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19991115)86:10<1966::aid-c

    authors: Takao S,Uchikura K,Yonezawa S,Shinchi H,Aikou T

    更新日期:1999-11-15 00:00:00

  • Quality of life of African-American and white long term breast carcinoma survivors.

    abstract:BACKGROUND:Increasingly, the quality of life (QOL) of women diagnosed with breast carcinoma is being studied. However, there is little information regarding long term survivors among ethnic minority women. The purpose of this study was to describe the QOL of long term breast carcinoma survivors (BCS) and to examine the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990115)85:2<418::aid-cnc

    authors: Ashing-Giwa K,Ganz PA,Petersen L

    更新日期:1999-01-15 00:00:00

  • Favorable prognosis after late relapse of Hodgkin's disease.

    abstract:BACKGROUND:Most relapses of Hodgkin's disease (HD) occur within the first 2 years after diagnosis, but they may develop after a longer observation period. The aim of this study was to define the incidence, clinical course, and prognostic factors for late relapse (LR) of Hodgkin's disease. For this purpose, the authors ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Garcia-Carbonero R,Paz-Ares L,Arcediano A,Lahuerta J,Bartolome A,Cortes-Funes H

    更新日期:1998-08-01 00:00:00

  • Latent Epstein-Barr virus infection is an unlikely event in the pathogenesis of immunoproliferative small intestinal disease.

    abstract:BACKGROUND:The observed seasonal and geographic variations in the incidence of immunoproliferative small intestinal disease (IPSID) suggest that environmental factors contribute to its pathogenesis. One such environmental factor, the Epstein-Barr virus (EBV), has been associated with other B-cell lymphoproliferative di...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940915)74:6<1699::aid-cncr2820

    authors: Baddoura FK,Unger ER,Mufarrij A,Nassar VH,Zaki SR

    更新日期:1994-09-15 00:00:00